Dexmethylphenidate marketed by Actavis Pharma, Inc. under NDC Code 45963-807-11
NDC Code(s) : 45963-833-11, 45963-806-11, 45963-805-11, 45963-804-11, 45963-807-11
Packager : Actavis Pharma, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Dexmethylphenidate hydrochlorideDexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE |
|
|
|
|
|
|
Dexmethylphenidate hydrochlorideDexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE |
|
|
|
|
|
|
Dexmethylphenidate hydrochlorideDexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE |
|
|
|
|
|
|
Dexmethylphenidate hydrochlorideDexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE |
|
|
|
|
|
|
Dexmethylphenidate hydrochlorideDexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE |
|
|
|
|
|
|
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.